Learn about our rebrand Learn More
Washington, DC (January 27, 2025) – The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma, is excited to announce the official ...
Melanoma is a lethal form of skin cancer because it has a high propensity to metastasize, especially to the brain (often causing death). Compounding this problem is the obs...
Description: Mucosal melanoma (MM) is a rare form of melanoma with poor survival outcomes. Data on treatment for MM is limited to results from studies on cutaneous melanoma...
Description: For patients with melanoma, timely diagnosis and prompt treatment are important for optimal outcomes, but some groups of patients may face barriers to accessin...
Description: Pigmentation, or the coloring of the skin, hair and mucous membranes, has been shown to influence melanoma risk. Most, if not all traits and diseases, have a g...
Description: Findings from this grant will shed light on 1) how stemness is sustained by modulating PI3Kδ signaling in T cells using FDA-approved drugs and 2) how transcri...
Description: While immunotherapy treatment has radically improved the outcomes of patients with advanced melanoma, around half of patients have no response. This is in part...
Description: According to the latest published statistics by the NIH, there are almost half a million individuals who are cancer survivors after having been diagnosed with ...
Description: While several medications, immune stimulating agents, and radiation therapies have been developed and used for the treatment of melanoma, the treatment options...
Description: Hybrid cells, in circulation and in the tumor are reprogrammed cancer cells displaying immune cell mimicry—insights into their impact on tumor progression, i...
Description: Background: Racial inequities in melanoma survival have been documented in the literature. The largest Black-white difference in overall cancer survival is for...
Description: Immunotherapy has been shown to be effective in treating melanoma, even at an early stage of disease. Patients with Stage II melanoma are now able to receive a...
Apr 26, 2025 - Apr 27, 2025
